These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3274533)

  • 1. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
    Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year.
    Eid A; Perkins JD; Rakela J; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2238-9. PubMed ID: 2652725
    [No Abstract]   [Full Text] [Related]  

  • 3. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract]   [Full Text] [Related]  

  • 7. Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
    Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Yoshida T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1628-30. PubMed ID: 2652531
    [No Abstract]   [Full Text] [Related]  

  • 8. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients.
    Kupin W; Venkat KK; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1623-4. PubMed ID: 2652528
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved immunosuppression for heart transplantation.
    Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.
    Paradis K; al Edreesi M; St-Vil D; Laberge JM; Dupuis C; Rasquin-Weber A
    Transplant Proc; 1994 Oct; 26(5):2777-8. PubMed ID: 7940875
    [No Abstract]   [Full Text] [Related]  

  • 11. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT; Antolick A; Ring WS
    J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid abnormalities in renal transplant recipients treated with cyclosporine.
    Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Dunn J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1989 Aug; 21(4):3670-3. PubMed ID: 2669278
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
    Porayko MK; Textor SC; Krom RA; Hay JE; Gores GJ; Wahlstrom HE; Sanchez-Urdazpal L; Richards T; Crotty P; Beaver S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):665-8. PubMed ID: 7679835
    [No Abstract]   [Full Text] [Related]  

  • 14. Amelioration of 3.5-hour warm ischemia time for pig livers by cyclosporine pretherapy, compared with azathioprine.
    Kim YI; Kawano K; Goto S; Ono M; Iwao Y; Kobayashi M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):655-6. PubMed ID: 1990637
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG; Lodge JP
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract]   [Full Text] [Related]  

  • 17. Current results with triple therapy for heart transplantation.
    Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544
    [No Abstract]   [Full Text] [Related]  

  • 18. Elective cyclosporine conversion from triple therapy.
    Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.